Plasma NF-L may be a useful biomarker for identifying the rapidly progressive subtype of PD, whereas plasma NF-L, UCH-L1, and t-tau may also contribute to the prognostic prediction of PD at different stages. The gene discussed is NEFL; the disease is Parkinson disease.